These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12422248)

  • 21. SP-01A helps with quality of life.
    AIDS Patient Care STDS; 2008 Feb; 22(2):160-1. PubMed ID: 18273942
    [No Abstract]   [Full Text] [Related]  

  • 22. AIDS: the first 25 years.
    Friedland GH
    AIDS Clin Care; 2006 Jun; 18(6):53-4. PubMed ID: 16791953
    [No Abstract]   [Full Text] [Related]  

  • 23. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment.
    Nguyen VK; Ako CY; Niamba P; Sylla A; Tiendrébéogo I
    AIDS; 2007 Oct; 21 Suppl 5():S31-5. PubMed ID: 18090265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 and HIV-Associated Nephropathy 25 Years Later.
    Wyatt CM; Klotman PE
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S20-4. PubMed ID: 17699507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching antiretroviral therapy: why, when and how.
    Wilkin T; Glesby M; Gulick RM
    IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
    [No Abstract]   [Full Text] [Related]  

  • 26. A historical sketch of the discovery and development of HIV-1 integrase inhibitors.
    Savarino A
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1507-22. PubMed ID: 17107277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten years of HAART.
    Harrington M
    Res Initiat Treat Action; 2005; 11(1):28-38. PubMed ID: 16208817
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-HIV nucleoside drugs: retrospective view at future].
    Kukhanova MK
    Mol Biol (Mosk); 2012; 46(6):860-73. PubMed ID: 23350232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A brief history of antiretroviral therapy of HIV infection: success and challenges.
    Palmisano L; Vella S
    Ann Ist Super Sanita; 2011; 47(1):44-8. PubMed ID: 21430338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
    Lagnese M; Daar ES
    Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HAART at 10--a CFA timeline.
    Res Initiat Treat Action; 2005; 11(1):6-27. PubMed ID: 16208816
    [No Abstract]   [Full Text] [Related]  

  • 32. The history of antiretrovirals: key discoveries over the past 25 years.
    De Clercq E
    Rev Med Virol; 2009 Sep; 19(5):287-99. PubMed ID: 19714702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lack of compliance means no success].
    Kuhlmann B
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():18-9. PubMed ID: 16385864
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance mutations in HIV-1.
    D'Aquila RT; Schapiro JM; Brun-Vézinet F; Clotet B; Conway B; Demeter LM; Grant RM; Johnson VA; Kuritzkes DR; Loveday C; Shafer RW; Richman DD
    Top HIV Med; 2003; 11(3):92-6. PubMed ID: 12837968
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
    De Clercq E
    Int J Antimicrob Agents; 2009 Apr; 33(4):307-20. PubMed ID: 19108994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV and AIDS: 20 years of science.
    Fauci AS
    Nat Med; 2003 Jul; 9(7):839-43. PubMed ID: 12835701
    [No Abstract]   [Full Text] [Related]  

  • 39. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.
    Koyalta D; Charpentier C; Beassamda J; Rey E; Si-Mohamed A; Djemadji-Oudjeil N; Bélec L
    Clin Infect Dis; 2009 Jul; 49(1):155-9. PubMed ID: 19480574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Highly active initial therapy without resistance development. Even after 6 years still effective HIV therapy].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():54-5. PubMed ID: 16385876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.